Due to the pandemic, the Annual General Meeting of Roche Holding Ltd will take place on 16 March 2021 without the physical presence of shareholders and with only the persons required by the Articles of Incorporation in attendance During the Annual General Meeting, shareholders’ rights will be exercised exclusively via the independent proxy, without the... Read more
Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep WALTHAM, Mass. and LYON, France, Jan. 15, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry, today announced that Thermo Fisher has completed... Read more
Hamburg, January 14, 2021 Streamlining the transfer of an upstream bioprocess from research to production scale is critical for reducing biologics development costs and time to market. Eppendorf, a leading life science company, introduces the BioFlo 720, a bioprocess control station for applications at pilot/production scale using single-use bioreactors. With it, Eppendorf now offers one of... Read more
Novel test supports vaccine development studies critical to aiding researchersin understanding immunity levels and disease progression WALTHAM, Mass. – January 14, 2021 – PerkinElmer today announced that its EUROIMMUN business has launched a SARS-CoV-2 Interferon Gamma Release Assay (IGRA) for Research Use Only (RUO) to determine the activity of T-cells reactive to SARS-CoV-2, the pathogen... Read more
Gold-standard testing of individuals without COVID-19 symptoms key to controlling the spread WALTHAM, Mass. –(BUSINESS WIRE)–Jan. 14, 2021– PerkinElmer, Inc. (NYSE:PKI) announced today that its PerkinElmer ® New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization (EUA) Read more
Subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 13, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its fourth quarter 2020 results at 6:55 a.m. (ET) on Thursday, February 4, 2021. At 9:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more
MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced a multi-year collaboration with Invitae Corporation (NYSE: NVTA), a leading medical genetics company, to begin development of a production-scale high-throughput sequencing platform leveraging the power of PacBio’s highly accurate... Read more
MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced a multi-year collaboration with Invitae Corporation (NYSE: NVTA), a leading medical genetics company, to begin development of a production-scale high-throughput sequencing platform leveraging the power of PacBio’s highly accurate... Read more
MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced a multi-year collaboration with Invitae Corporation (NYSE: NVTA), a leading medical genetics company, to begin development of a production-scale high-throughput sequencing platform leveraging the power of PacBio’s highly accurate... Read more